<i>STAT4</i> genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China-Reference-Cited by-同舟云学术

STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China

Published:2022-06 Issue:9 Volume:94 Page:4449-4458
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Qi Xun¹²,Li Fahong¹,Zhang Yao¹,Zhu Haoxiang¹,Yang Feifei¹,Li Xinyan²,Jiang Xuhua²,Chen Liang²,Huang Yuxian¹²,Zhang Jiming¹³⁴^ORCID

Affiliation:

1. Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital Fudan University Shanghai China

2. Department of Hepatology, Shanghai Public Health Clinical Center Fudan University Shanghai China

3. Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Medical College Fudan University Shanghai China

4. Department of Infectious Diseases, Jing'An Branch of Huashan Hospital Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Shanghai Shen Kang Hospital Development Center

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27880